Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 18.514\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) COc1ccc(-c2cn(-c3ccc(C)cc3C)c(=S)[nH]2)cc1OC
(b) CC(C)C(NC(=O)c1ccc2c(c1)OCO2)C(=O)N/N=C/c1cccs1
Answer: b. CC(C)C(NC(=O)c1ccc2c(c1)OCO2)C(=O)N/N=C/c1cccs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(NC(=O)c1ccc2c(c1)OCO2)C(=O)N/N=C/c1cccs1
CC(C)C(NC(=O)c1ccc2c(c1)OCO2)C(=O)N/N=C/c1cccs1
N-[3-methyl-1-oxo-1-[(2E)-2-(thiophen-2-ylmethylidene)hydrazinyl]butan-2-yl]-1,3-benzodioxole-5-carboxamide